title: Posterior reversible encephalopathy syndrome due to immunosuppressant after living-donor lobar lung transplantation: report of a case.
abstract: Living-donor lobar lung transplantation was performed in a 10-year-old boy with bronchiolitis obliterans after bone marrow transplantation for recurrent acute myeloid leukemia. He developed posterior reversible encephalopathy syndrome (PRES) due to calcineurin inhibitor (CNI) postoperatively, which was recovered with suspension of CNI. PRES should be considered one of the important morbidity after lung transplantation.
authors.affiliation: Department of Thoracic Surgery, Kyoto University, 54 Shogoin-Kawahara-cho, Sakyo-ku, Kyoto, Japan. tshoji@kuhp.kyoto-u.ac.jp
authors.forename: Tsuyoshi
authors.initials: T
authors.lastname: Shoji
authors.forename: Toru
authors.initials: T
authors.lastname: Bando
authors.forename: Takuji
authors.initials: T
authors.lastname: Fujinaga
authors.forename: Fengshi
authors.initials: F
authors.lastname: Chen
authors.forename: Mitsutomo
authors.initials: M
authors.lastname: Kohno
authors.forename: Miharu
authors.initials: M
authors.lastname: Yabe
authors.forename: Hiromasa
authors.initials: H
authors.lastname: Yabe
authors.forename: Hiroshi
authors.initials: H
authors.lastname: Date
mesh_terms: D016026:Bone Marrow Transplantation / Q000009:adverse effects*; D001989:Bronchiolitis Obliterans / Q000209:etiology / Q000601:surgery*; D065095:Calcineurin Inhibitors; D002648:Child; D006801:Humans; D007166:Immunosuppressive Agents / Q000009:adverse effects*; D015470:Leukemia, Myeloid, Acute / Q000601:surgery*; D019520:Living Donors; D016040:Lung Transplantation / Q000276:immunology*; D008279:Magnetic Resonance Imaging; D008297:Male; D054038:Posterior Leukoencephalopathy Syndrome / Q000139:chemically induced* / Q000175:diagnosis
chemical_list: D065095:Calcineurin Inhibitors; D007166:Immunosuppressive Agents